Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

Clinical trial NCT02175719 · COMPLETED

Trial details

NCT number: NCT02175719
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Cervical Dystonia

Start date: 2013-04-16
Primary completion: 2017-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.